Saturday, January 25, 2025

CATEGORY

WHO

WHO Endorses First Single-Dose Treatment for P. vivax Malaria

Key TakeawaysTafenoquine's approval accelerates malaria elimination efforts in multiple countries. The need for G6PD testing ensures safe administration, mitigating potential risks. Collaboration between...

EPF Empowers Patient Groups with New Anti-AMR Toolkit

Key TakeawaysLeverage EPF’s toolkit to raise awareness about the dangers of AMR and the importance of responsible antibiotic use within your communities. Participate...

Korea and WHO Discuss Future Health Security at Bio Summit

Key TakeawaysKorea and WHO focus on global health cooperation at World Bio Summit 2024. Discussions emphasize lessons from COVID-19 and future health care...

Regulators Push for Coordinated Mpox Vaccine Trials

Recent global health concerns have spotlighted mpox, a viral disease endemic to parts of Central and West Africa, as a significant threat. As cases...

G-BA Approves Updates to COVID-19 Vaccination Guidelines

In a significant development for Germany's public health policy, the Gemeinsame Bundesausschuss (G-BA) has revised the Schutzimpfungs-Richtlinie concerning COVID-19 vaccinations. Aligning with the latest...

Johnson & Johnson’s New Data Highlights Promising Neuropsychiatry Advances

Johnson & Johnson continues to blaze a trail in the field of neuroscience, reinforcing its commitment to addressing complex mental health challenges through innovation....

G-BA Greenlights Clinical Trial for Novel Pancreatic Cancer Treatment

Pancreatic cancer, notorious for its aggressive nature and limited treatment options, sees a potential breakthrough as the German Federal Joint Committee (G-BA) announces a...

Roche’s Evrysdi Shows Promising Results in Early SMA Treatment for Infants

Roche has unveiled promising data from its RAINBOWFISH study, highlighting Evrysdi's efficacy and safety in treating spinal muscular atrophy (SMA) in infants. This groundbreaking...

WHO Calls for Key Data on COVID-19 Vaccine Antigen Composition Ahead of December 2024 Deliberations

Key TakeawaysWHO’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) requests specific data on SARS-CoV-2 variants and vaccine performance to inform the upcoming...

WHO Global Advisory Committee on Vaccine Safety Reviews Mpox Vaccines for High-Risk Groups Amid Resurgence

Key TakeawaysWHO's Global Advisory Committee on Vaccine Safety (GACVS) reviewed updated safety data for mpox vaccines amid rising cases in Africa, with special...

Germany Shifts Influenza Vaccination Strategy to Trivalent Formulations for 2024

Key TakeawaysThe G-BA's decision to switch to trivalent influenza vaccines by September 2024 represents a major shift in vaccination strategy, aligned with WHO...

Cervical Cancer Prevention Guidelines Updated by WHO to Include Roche’s Dual-Stain Test

Key TakeawaysThe WHO has updated its guidelines to include Roche's CINtec PLUS Cytology test, which detects high-risk biomarkers for cervical cancer. This test...

WHO Endorses Dual-Stain Cytology for Cervical Cancer Screening

Key TakeawaysWHO now includes Roche’s CINtec® PLUS dual-stain cytology in cervical cancer prevention guidelines. This test aids in identifying HPV-positive individuals at higher...

UNICEF Issues Emergency Tender for Mpox Vaccines in Crisis-Hit Countries

Key TakeawaysUNICEF has launched an emergency tender to secure mpox vaccines for crisis-affected countries in collaboration with Africa CDC, Gavi, and WHO. The...

AMR at the Forefront: WHO Releases New Guidance to Help Manufacturers Mitigate Antimicrobial Resistance Risk

Key TakeawaysThe World Health Organization (WHO) has released its first-ever guidance on controlling antibiotic pollution during manufacturing to combat the global risk of...

Latest news